Lv6
2280 积分 2023-07-20 加入
First-Line Camizestrant for Emerging ESR1 -Mutated Advanced Breast Cancer
14小时前
已完结
US Food and Drug Administration Approval Summary: Fam-Trastuzumab Deruxtecan-nxki for Human Epidermal Growth Factor Receptor 2-Low Unresectable or Metastatic Breast Cancer
5天前
已完结
Ethics of Backfilling in Early-Phase Oncology Trials
3个月前
已完结
Analysis of phase II and phase III clinical trial terminations from 2013 to 2023
6个月前
已关闭
Interstitial lung disease biomarkers: a systematic review and meta-analysis
6个月前
已完结
Interstitial lung disease in targeted therapies: A Society of Gynecologic Oncology clinical practice statement
6个月前
已完结
Incidence of antibody–drug conjugates-related pneumonitis in patients with solid tumors: A systematic review and meta-analysis
6个月前
已完结
Radiation Pneumonitis
6个月前
已完结
The effect of adding immune checkpoint inhibitors on the risk of pneumonitis for solid tumours: a meta-analysis of phase III randomised controlled trials
6个月前
已完结
Immune checkpoint inhibitor-related pneumonitis: From guidelines to the front lines
6个月前
已完结
皖公网安备34019202002308
